Click for best price
Uveitis Treatment Drug Market Size, Share 2024
The global Uveitis Treatment Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Corticosteroids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Uveitis Treatment Drug include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd. and Bausch & Lomb Incorporated, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Uveitis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uveitis Treatment Drug. This report contains market size and forecasts of Uveitis Treatment Drug in global, including the following market information:
Global Uveitis Treatment Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Uveitis Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Uveitis Treatment Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Uveitis Treatment Drug Market Segment Percentages, by Type, 2023 (%)
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Antibiotics
Others
Global Uveitis Treatment Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Uveitis Treatment Drug Market Segment Percentages, by Application, 2023 (%)
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan Uveitis
Global Uveitis Treatment Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Uveitis Treatment Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Uveitis Treatment Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Uveitis Treatment Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Novartis AG
Bausch Health Companies Inc.
Galapagos NV
EyePoint Pharmaceuticals, Inc.
Clearside Biomedical
Tarsier Pharma Ltd
Santen Pharmaceutical Co., Ltd.
Bausch & Lomb Incorporated
Sanofi
Regeneron Pharmaceuticals, Inc.
Alimera Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Uveitis Treatment Drug, market overview.
Chapter 2: Global Uveitis Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Uveitis Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Uveitis Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Uveitis Treatment Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Uveitis Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Uveitis Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Uveitis Treatment Drug Overall Market Size
2.1 Global Uveitis Treatment Drug Market Size: 2023 VS 2030
2.2 Global Uveitis Treatment Drug Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Uveitis Treatment Drug Players in Global Market
3.2 Top Global Uveitis Treatment Drug Companies Ranked by Revenue
3.3 Global Uveitis Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Uveitis Treatment Drug Companies in Global Market, by Revenue in 2023
3.5 Global Companies Uveitis Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Uveitis Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Uveitis Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Uveitis Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Uveitis Treatment Drug Market Size Markets, 2023 & 2030
4.1.2 Corticosteroids
4.1.3 Immunosuppressant
4.1.4 Monoclonal Antibodies
4.1.5 Antibiotics
4.1.6 Others
4.2 By Type - Global Uveitis Treatment Drug Revenue & Forecasts
4.2.1 By Type - Global Uveitis Treatment Drug Revenue, 2019-2024
4.2.2 By Type - Global Uveitis Treatment Drug Revenue, 2025-2030
4.2.3 By Type - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Uveitis Treatment Drug Market Size, 2023 & 2030
5.1.2 Anterior Uveitis
5.1.3 Posterior Uveitis
5.1.4 Intermediate Uveitis
5.1.5 Pan Uveitis
5.2 By Application - Global Uveitis Treatment Drug Revenue & Forecasts
5.2.1 By Application - Global Uveitis Treatment Drug Revenue, 2019-2024
5.2.2 By Application - Global Uveitis Treatment Drug Revenue, 2025-2030
5.2.3 By Application - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Uveitis Treatment Drug Market Size, 2023 & 2030
6.2 By Region - Global Uveitis Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Uveitis Treatment Drug Revenue, 2019-2024
6.2.2 By Region - Global Uveitis Treatment Drug Revenue, 2025-2030
6.2.3 By Region - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Uveitis Treatment Drug Revenue, 2019-2030
6.3.2 US Uveitis Treatment Drug Market Size, 2019-2030
6.3.3 Canada Uveitis Treatment Drug Market Size, 2019-2030
6.3.4 Mexico Uveitis Treatment Drug Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Uveitis Treatment Drug Revenue, 2019-2030
6.4.2 Germany Uveitis Treatment Drug Market Size, 2019-2030
6.4.3 France Uveitis Treatment Drug Market Size, 2019-2030
6.4.4 U.K. Uveitis Treatment Drug Market Size, 2019-2030
6.4.5 Italy Uveitis Treatment Drug Market Size, 2019-2030
6.4.6 Russia Uveitis Treatment Drug Market Size, 2019-2030
6.4.7 Nordic Countries Uveitis Treatment Drug Market Size, 2019-2030
6.4.8 Benelux Uveitis Treatment Drug Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Uveitis Treatment Drug Revenue, 2019-2030
6.5.2 China Uveitis Treatment Drug Market Size, 2019-2030
6.5.3 Japan Uveitis Treatment Drug Market Size, 2019-2030
6.5.4 South Korea Uveitis Treatment Drug Market Size, 2019-2030
6.5.5 Southeast Asia Uveitis Treatment Drug Market Size, 2019-2030
6.5.6 India Uveitis Treatment Drug Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Uveitis Treatment Drug Revenue, 2019-2030
6.6.2 Brazil Uveitis Treatment Drug Market Size, 2019-2030
6.6.3 Argentina Uveitis Treatment Drug Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Uveitis Treatment Drug Revenue, 2019-2030
6.7.2 Turkey Uveitis Treatment Drug Market Size, 2019-2030
6.7.3 Israel Uveitis Treatment Drug Market Size, 2019-2030
6.7.4 Saudi Arabia Uveitis Treatment Drug Market Size, 2019-2030
6.7.5 UAE Uveitis Treatment Drug Market Size, 2019-2030
7 Uveitis Treatment Drug Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Uveitis Treatment Drug Major Product Offerings
7.1.4 AbbVie Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Uveitis Treatment Drug Major Product Offerings
7.2.4 Novartis AG Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.2.5 Novartis AG Key News & Latest Developments
7.3 Bausch Health Companies Inc.
7.3.1 Bausch Health Companies Inc. Company Summary
7.3.2 Bausch Health Companies Inc. Business Overview
7.3.3 Bausch Health Companies Inc. Uveitis Treatment Drug Major Product Offerings
7.3.4 Bausch Health Companies Inc. Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.3.5 Bausch Health Companies Inc. Key News & Latest Developments
7.4 Galapagos NV
7.4.1 Galapagos NV Company Summary
7.4.2 Galapagos NV Business Overview
7.4.3 Galapagos NV Uveitis Treatment Drug Major Product Offerings
7.4.4 Galapagos NV Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.4.5 Galapagos NV Key News & Latest Developments
7.5 EyePoint Pharmaceuticals, Inc.
7.5.1 EyePoint Pharmaceuticals, Inc. Company Summary
7.5.2 EyePoint Pharmaceuticals, Inc. Business Overview
7.5.3 EyePoint Pharmaceuticals, Inc. Uveitis Treatment Drug Major Product Offerings
7.5.4 EyePoint Pharmaceuticals, Inc. Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.5.5 EyePoint Pharmaceuticals, Inc. Key News & Latest Developments
7.6 Clearside Biomedical
7.6.1 Clearside Biomedical Company Summary
7.6.2 Clearside Biomedical Business Overview
7.6.3 Clearside Biomedical Uveitis Treatment Drug Major Product Offerings
7.6.4 Clearside Biomedical Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.6.5 Clearside Biomedical Key News & Latest Developments
7.7 Tarsier Pharma Ltd
7.7.1 Tarsier Pharma Ltd Company Summary
7.7.2 Tarsier Pharma Ltd Business Overview
7.7.3 Tarsier Pharma Ltd Uveitis Treatment Drug Major Product Offerings
7.7.4 Tarsier Pharma Ltd Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.7.5 Tarsier Pharma Ltd Key News & Latest Developments
7.8 Santen Pharmaceutical Co., Ltd.
7.8.1 Santen Pharmaceutical Co., Ltd. Company Summary
7.8.2 Santen Pharmaceutical Co., Ltd. Business Overview
7.8.3 Santen Pharmaceutical Co., Ltd. Uveitis Treatment Drug Major Product Offerings
7.8.4 Santen Pharmaceutical Co., Ltd. Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.8.5 Santen Pharmaceutical Co., Ltd. Key News & Latest Developments
7.9 Bausch & Lomb Incorporated
7.9.1 Bausch & Lomb Incorporated Company Summary
7.9.2 Bausch & Lomb Incorporated Business Overview
7.9.3 Bausch & Lomb Incorporated Uveitis Treatment Drug Major Product Offerings
7.9.4 Bausch & Lomb Incorporated Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.9.5 Bausch & Lomb Incorporated Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Uveitis Treatment Drug Major Product Offerings
7.10.4 Sanofi Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.10.5 Sanofi Key News & Latest Developments
7.11 Regeneron Pharmaceuticals, Inc.
7.11.1 Regeneron Pharmaceuticals, Inc. Company Summary
7.11.2 Regeneron Pharmaceuticals, Inc. Business Overview
7.11.3 Regeneron Pharmaceuticals, Inc. Uveitis Treatment Drug Major Product Offerings
7.11.4 Regeneron Pharmaceuticals, Inc. Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.11.5 Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
7.12 Alimera Sciences
7.12.1 Alimera Sciences Company Summary
7.12.2 Alimera Sciences Business Overview
7.12.3 Alimera Sciences Uveitis Treatment Drug Major Product Offerings
7.12.4 Alimera Sciences Uveitis Treatment Drug Revenue in Global Market (2019-2024)
7.12.5 Alimera Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Uveitis Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Uveitis Treatment Drug Market Drivers in Global Market
Table 3. Uveitis Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Uveitis Treatment Drug in Global Market
Table 5. Top Uveitis Treatment Drug Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Uveitis Treatment Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Uveitis Treatment Drug Revenue Share by Companies, 2019-2024
Table 8. Global Companies Uveitis Treatment Drug Product Type
Table 9. List of Global Tier 1 Uveitis Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Uveitis Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Uveitis Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Uveitis Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Uveitis Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Uveitis Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Uveitis Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Uveitis Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Uveitis Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Uveitis Treatment Drug Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Uveitis Treatment Drug Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Uveitis Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Uveitis Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Uveitis Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Uveitis Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Uveitis Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Uveitis Treatment Drug Product Offerings
Table 32. AbbVie Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 33. AbbVie Key News & Latest Developments
Table 34. Novartis AG Company Summary
Table 35. Novartis AG Uveitis Treatment Drug Product Offerings
Table 36. Novartis AG Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 37. Novartis AG Key News & Latest Developments
Table 38. Bausch Health Companies Inc. Company Summary
Table 39. Bausch Health Companies Inc. Uveitis Treatment Drug Product Offerings
Table 40. Bausch Health Companies Inc. Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 41. Bausch Health Companies Inc. Key News & Latest Developments
Table 42. Galapagos NV Company Summary
Table 43. Galapagos NV Uveitis Treatment Drug Product Offerings
Table 44. Galapagos NV Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 45. Galapagos NV Key News & Latest Developments
Table 46. EyePoint Pharmaceuticals, Inc. Company Summary
Table 47. EyePoint Pharmaceuticals, Inc. Uveitis Treatment Drug Product Offerings
Table 48. EyePoint Pharmaceuticals, Inc. Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 49. EyePoint Pharmaceuticals, Inc. Key News & Latest Developments
Table 50. Clearside Biomedical Company Summary
Table 51. Clearside Biomedical Uveitis Treatment Drug Product Offerings
Table 52. Clearside Biomedical Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 53. Clearside Biomedical Key News & Latest Developments
Table 54. Tarsier Pharma Ltd Company Summary
Table 55. Tarsier Pharma Ltd Uveitis Treatment Drug Product Offerings
Table 56. Tarsier Pharma Ltd Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 57. Tarsier Pharma Ltd Key News & Latest Developments
Table 58. Santen Pharmaceutical Co., Ltd. Company Summary
Table 59. Santen Pharmaceutical Co., Ltd. Uveitis Treatment Drug Product Offerings
Table 60. Santen Pharmaceutical Co., Ltd. Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 61. Santen Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 62. Bausch & Lomb Incorporated Company Summary
Table 63. Bausch & Lomb Incorporated Uveitis Treatment Drug Product Offerings
Table 64. Bausch & Lomb Incorporated Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 65. Bausch & Lomb Incorporated Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Uveitis Treatment Drug Product Offerings
Table 68. Sanofi Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 69. Sanofi Key News & Latest Developments
Table 70. Regeneron Pharmaceuticals, Inc. Company Summary
Table 71. Regeneron Pharmaceuticals, Inc. Uveitis Treatment Drug Product Offerings
Table 72. Regeneron Pharmaceuticals, Inc. Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 73. Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
Table 74. Alimera Sciences Company Summary
Table 75. Alimera Sciences Uveitis Treatment Drug Product Offerings
Table 76. Alimera Sciences Uveitis Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 77. Alimera Sciences Key News & Latest Developments
List of Figures
Figure 1. Uveitis Treatment Drug Segment by Type in 2023
Figure 2. Uveitis Treatment Drug Segment by Application in 2023
Figure 3. Global Uveitis Treatment Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Uveitis Treatment Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Uveitis Treatment Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Uveitis Treatment Drug Revenue in 2023
Figure 8. By Type - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 9. By Application - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 10. By Type - Global Uveitis Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 12. By Application - Global Uveitis Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 14. By Region - Global Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 15. By Country - North America Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 16. US Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 20. Germany Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 21. France Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 28. China Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 32. India Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 34. Brazil Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Uveitis Treatment Drug Revenue Market Share, 2019-2030
Figure 37. Turkey Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Uveitis Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 41. AbbVie Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Novartis AG Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bausch Health Companies Inc. Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Galapagos NV Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. EyePoint Pharmaceuticals, Inc. Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Clearside Biomedical Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Tarsier Pharma Ltd Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Santen Pharmaceutical Co., Ltd. Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Bausch & Lomb Incorporated Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Sanofi Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Regeneron Pharmaceuticals, Inc. Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Alimera Sciences Uveitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
